Smoking and intermediate alpha1-antitrypsin deficiency and lung function in middle-aged men

Area of Science:

• Pulmonary Medicine
• Genetics
• Respiratory Health

Background:

• Alpha1-antitrypsin deficiency (AATD) is a genetic condition that increases the risk of lung disease.
• Heterozygous carriers (PiZ phenotype) may have subtle lung function changes, especially when exposed to environmental factors like smoking.

Purpose of the Study:

• To investigate the impact of smoking on lung function in men heterozygous for alpha1-antitrypsin deficiency (PiZ phenotype).
• To compare lung function between smoking and non-smoking PiZ individuals and PiM controls.

Main Methods:

• A population sample of 50-year-old men was studied.
• Subjects included smoking and non-smoking men with PiZ phenotype, matched with PiM controls for weight and smoking habits.
• Pulmonary function tests were used to evaluate lung function parameters.

Main Results:

• Non-smoking PiZ subjects exhibited normal lung function comparable to PiM controls.
• Smoking PiZ individuals demonstrated significant reductions in elastic recoil, increased residual volumes, and elevated closing capacity.
• No obstructive ventilatory impairment was observed in smoking PiZ subjects, though mild exertional dyspnea was reported.

Conclusions:

• Smoking significantly impairs lung function in heterozygous alpha1-antitrypsin deficiency carriers (PiZ phenotype).
• The observed lung function changes in smoking PiZ individuals suggest susceptibility to lung damage beyond typical smoking effects.
• Early identification and smoking cessation are crucial for individuals with PiZ phenotype to mitigate respiratory health risks.